Hitoshi Nakano

910 total citations
66 papers, 666 citations indexed

About

Hitoshi Nakano is a scholar working on Endocrine and Autonomic Systems, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Hitoshi Nakano has authored 66 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrine and Autonomic Systems, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Epidemiology. Recurrent topics in Hitoshi Nakano's work include Neuroscience of respiration and sleep (17 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (7 papers). Hitoshi Nakano is often cited by papers focused on Neuroscience of respiration and sleep (17 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (7 papers). Hitoshi Nakano collaborates with scholars based in Japan, United States and Netherlands. Hitoshi Nakano's co-authors include Shin‐Da Lee, Shinobu Osanai, G. A. Farkas, Hiroshi Ide, Jun Iwamoto, John A. Krasney, Ulysses J. Magalang, Kenjiro Kikuchi, Toru Takahashi and Kiichirô Yamamoto and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Applied Physiology and Advances in experimental medicine and biology.

In The Last Decade

Hitoshi Nakano

60 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Nakano Japan 15 191 184 172 146 74 66 666
Shinobu Osanai Japan 16 195 1.0× 357 1.9× 297 1.7× 57 0.4× 146 2.0× 62 852
P. Cauchie Belgium 13 87 0.5× 51 0.3× 124 0.7× 108 0.7× 23 0.3× 43 621
Tünde Farkas-Szallasi United States 11 511 2.7× 142 0.8× 214 1.2× 94 0.6× 24 0.3× 12 1.2k
Christiane Sokollik Switzerland 15 113 0.6× 83 0.5× 127 0.7× 150 1.0× 102 1.4× 36 705
Song Zhang China 16 155 0.8× 83 0.5× 39 0.2× 122 0.8× 100 1.4× 39 1.1k
İlknur Erol Türkiye 18 77 0.4× 39 0.2× 51 0.3× 153 1.0× 79 1.1× 78 896
K Hatakeyama Japan 16 65 0.3× 63 0.3× 73 0.4× 91 0.6× 33 0.4× 36 850
A Pfister France 13 263 1.4× 27 0.1× 152 0.9× 66 0.5× 31 0.4× 47 943
Christian Folwaczny Germany 19 413 2.2× 540 2.9× 52 0.3× 449 3.1× 300 4.1× 29 1.6k
Wendy E. Walker United States 16 258 1.4× 360 2.0× 64 0.4× 249 1.7× 53 0.7× 29 1.3k

Countries citing papers authored by Hitoshi Nakano

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Nakano more than expected).

Fields of papers citing papers by Hitoshi Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Nakano. The network helps show where Hitoshi Nakano may publish in the future.

Co-authorship network of co-authors of Hitoshi Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Nakano. A scholar is included among the top collaborators of Hitoshi Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Nakano. Hitoshi Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruyama, Shuhei, Yasushi Nakamori, Hitoshi Nakano, et al.. (2022). Peak value of serum KL-6 may be useful for predicting poor prognosis of severe COVID-19 patients. European journal of medical research. 27(1). 69–69. 7 indexed citations
2.
Kinoshita, Masako, et al.. (2016). Imbalance in multiple sclerosis and neuromyelitis optica: association with deep sensation disturbance. Neurological Sciences. 37(12). 1961–1968. 2 indexed citations
3.
Takahashi, Toru, Shinobu Osanai, Hitoshi Nakano, Yoshinobu Ohsaki, & Kenjiro Kikuchi. (2005). Doxapram stimulates the carotid body via a different mechanism than hypoxic chemotransduction. Respiratory Physiology & Neurobiology. 147(1). 1–9. 9 indexed citations
4.
Osanai, Shinobu, Toru Takahashi, Hitoshi Nakano, Yoshinobu Ohsaki, & Kenjiro Kikuchi. (2003). Effect of HERG-like Potassium Channel Blocker on the Carotid Body Chemoreception. Advances in experimental medicine and biology. 536. 117–122. 1 indexed citations
5.
Nakagawa, Naoki, Shinobu Osanai, Hiroshi Ide, et al.. (2003). Severe Pulmonary Hypertension Associated with Primary Sjoegren's Syndrome. Internal Medicine. 42(12). 1248–1252. 25 indexed citations
6.
Takahashi, Toru, Shinobu Osanai, Hitoshi Nakano, Yoshinobu Ohsaki, & Kenjiro Kikuchi. (2003). Doxapram Stimulates Carotid Body with Different Mechanisms from Hypoxic Chemotransduction. Advances in experimental medicine and biology. 536. 129–134. 2 indexed citations
7.
Yoshida, Koichi, et al.. (2002). Prevalence of seropositivity for hepatitis C virus in cataract patients and the general population. Journal of Cataract & Refractive Surgery. 28(10). 1789–1792. 8 indexed citations
8.
Nakano, Hitoshi, et al.. (2001). Serotonergic Modulation of Ventilation and Upper Airway Stability in Obese Zucker Rats. American Journal of Respiratory and Critical Care Medicine. 163(5). 1191–1197. 58 indexed citations
9.
Nakano, Hitoshi, et al.. (2001). Role of Nitric Oxide in Thermoregulation and Hypoxic Ventilatory Response in Obese Zucker Rats. American Journal of Respiratory and Critical Care Medicine. 164(3). 437–442. 26 indexed citations
10.
Nakano, Hitoshi, Hiroshi Ide, Masanobu Imada, et al.. (2000). Reduced Nasal Nitric Oxide in Diffuse Panbronchiolitis. American Journal of Respiratory and Critical Care Medicine. 162(6). 2218–2220. 45 indexed citations
11.
Fujiuchi, Satoru, Yasuhiro Yamazaki, Hitoshi Nakano, et al.. (1997). [Farmer's lung complicated by bilateral pneumothorax and mediastinal emphysema].. PubMed. 35(6). 650–5. 3 indexed citations
12.
Fujiuchi, Satoru, Shinobu Osanai, Yasuhiro Yamazaki, et al.. (1995). A Clinical Analysis of Lung Cancer in Women.. Haigan. 35(1). 43–48. 1 indexed citations
13.
Yamakawa, Yosuke, et al.. (1995). Thyroid Dysfunction Induced by Interferon Therapy for the Treatment of Hepatitis Type C. A Report of 4 Cases.. The Kurume Medical Journal. 42(4). 313–319.
14.
Nakano, Hitoshi, et al.. (1994). ArF excimer laser beam delivery systems for medical applications. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2131. 28–28.
15.
Osanai, Shinobu, et al.. (1992). [Minocycline-induced pneumonia and pleurisy--a case report].. PubMed. 30(2). 322–7. 3 indexed citations
16.
Ishii, Kunihide, Michio Sata, Ryukichi Kumashiro, et al.. (1990). Studies on anti-HCV in hepatocellular carcinoma with alcoholic cirrhosis.. Kanzo. 31(10). 1181–1185. 7 indexed citations
17.
Nakano, Hitoshi, Michio Sata, Hiroshi Suzuki, et al.. (1990). A case report of chronic hepatitis B associated with HTLV-I healthy carrier who showed Type I response (Merigan) to adenine arabinoside therapy.. Kanzo. 31(2). 205–210. 1 indexed citations
18.
Sata, Michio, Kunihide Ishii, Hiroshi Suzuki, et al.. (1989). Hepatitis B Vaccination in Alcoholics. Kansenshogaku zasshi. 63(1). 27–34. 5 indexed citations
19.
Yano, Yoichi, Michio Sata, Hiroshi Suzuki, et al.. (1988). A case of evolvement to HBV carrier after receiving blood positive for HBsAg.. Kanzo. 29(1). 81–85. 1 indexed citations
20.
ABE, Hirohiko, et al.. (1987). Clinical and pathological studies in severe alcoholic hepatitis.. Kanzo. 28(3). 297–304. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026